Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 62400-75-3 | MDL No. : | MFCD06661931 |
Formula : | C5H9NO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | HOBJEFOCIRXQKH-UHFFFAOYSA-N |
M.W : | 115.13 | Pubchem ID : | 558359 |
Synonyms : |
|
Num. heavy atoms : | 8 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.8 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 32.11 |
TPSA : | 49.33 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.82 cm/s |
Log Po/w (iLOGP) : | 0.85 |
Log Po/w (XLOGP3) : | -1.15 |
Log Po/w (WLOGP) : | -1.12 |
Log Po/w (MLOGP) : | -0.78 |
Log Po/w (SILICOS-IT) : | 0.37 |
Consensus Log Po/w : | -0.37 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | 0.24 |
Solubility : | 199.0 mg/ml ; 1.72 mol/l |
Class : | Highly soluble |
Log S (Ali) : | 0.61 |
Solubility : | 465.0 mg/ml ; 4.04 mol/l |
Class : | Highly soluble |
Log S (SILICOS-IT) : | -0.47 |
Solubility : | 38.7 mg/ml ; 0.337 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.5 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
83% | With sodium tetrahydroborate In methanol at 0 - 20℃; for 2 h; Inert atmosphere | To a stirred solution of methyl 5-oxopyrrolidine-2-carboxylate (9 g, 62.93 mmol) in MeOH (150 mL) under an argon atmosphere was added sodium borohydride (3.6 g, 95.2 mmol) at 0 oC. The reaction mixture was warmed to room temperature and stirred for 2 h. After consumption of starting material (monitored by TLC), the reaction mixture was quenched with concentrated HCl at 0 oC, filtered, and washed with MeOH (2 x 50 mL). The filtrate was concentrated in vacuo. The crude material was purified by column chromatography using 10percent MeOH: CH2Cl2 to afford 5-(hydroxymethyl) pyrrolidin-2-one (6 g, 83percent) as a colorless oil. LCMS: 116 (M+1); (column; X-Select CSH C-18 (50 × 3.0 mm, 3.5 µm); RT 0.44 min 5mM NH4OAc in water: ACN; 0.80 mL/min); TLC: 10percent MeOH/ CH2Cl2 (Rf: 0.3). |
83% | at 0 - 20℃; for 2 h; Inert atmosphere | Synthesis of 5-(hydroxymethyl) pyrrolidin-2-one To a stirred solution of methyl 5-oxopyrrolidine-2-carboxylate (9 g, 62.93 mmol) in MeOH (150 mL) under an argon atmosphere was added sodium borohydride (3.6 g, 95.2 mmol) at 0° C. The reaction mixture was warmed to room temperature and stirred for 2 h. After consumption of starting material (monitored by TLC), the reaction mixture was quenched with concentrated HCl at 0° C., filtered, and washed with MeOH (2*50 mL). The filtrate was concentrated in vacuo. The crude material was purified by column chromatography using 10percent MeOH: CH2Cl2 to afford 5-(hydroxymethyl) pyrrolidin-2-one (6 g, 83percent) as a colorless oil. LCMS: 116 (M+1); (column; X-Select CSH C-18 (50*3.0 mm, 3.5 μm); RT 0.44 min 5 mM NH4OAc in water: ACN; 0.80 mL/min); TLC: 10percent MeOH/CH2Cl2 (Rf: 0.3). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
80% | at 0 - 20℃; for 6 h; | NaBH4 (1.2 g, 30.0 mmol) was added slowly to a solution of J1 (8.0 g, 50.0 mmol) in ethanol (60 ml_) at 0 °C portionwise. The reaction mixture was allowed to stir at room temperature for 6 h. The mixture was quenched with concentrated HCI and the precipitated solid was filtered and purified by column chromatography on 100 - 200 silica gel with 8percent methanol in DCM as eluent to give pure J2 (4.7 g, 80percent) as pale yellow thick liquid. Rf: 0.1 (20percent MeOH in DCM, KMn04 active). 1H NMR (400 MHz, cf6-DMSO) δ 1 .65 - 1.78 (m, 1 H); 1.96 - 2.15 (m, 3H); 3.25 (m, 2H); 3.46 (m, 1 H); 3.92 (br. s., 1 H); 7.58 (br. s., 1 H). |
[ 142-78-9 ]
N-(2-Hydroxyethyl)dodecanamide
Similarity: 0.85
[ 6334-25-4 ]
N1,N1,N6,N6-Tetrakis(2-hydroxyethyl)adipamide
Similarity: 0.78
[ 142-78-9 ]
N-(2-Hydroxyethyl)dodecanamide
Similarity: 0.85
[ 6334-25-4 ]
N1,N1,N6,N6-Tetrakis(2-hydroxyethyl)adipamide
Similarity: 0.78
[ 68108-18-9 ]
(S)-4-Hydroxypyrrolidine-2-one
Similarity: 0.74
[ 68108-18-9 ]
(S)-4-Hydroxypyrrolidine-2-one
Similarity: 0.74